Skip to content

Effects of various dialysates on electrolytes, cardiovascular system, hospitalization rate, life prognosis

Effects of various dialysates on electrolytes, cardiovascular system, hospitalization rate, life prognosis - Influence of use of the same dialysate for a long time

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000034937
Enrollment
400
Registered
2018-12-01
Start date
2018-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis

Interventions

None listed

Sponsors

Kawashima Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who continue to use the same dialysate for 3 years or more Stable maintaining dialysis patient

Exclusion criteria

Exclusion criteria: Patients with peritoneal dialysis combined

Design outcomes

Primary

MeasureTime frame
Mortality rate Hospitalization rate, re-hospitalization rate Corrected Ca, P, intact-PTH, Mg Abdominal CT:calcification score

Secondary

MeasureTime frame
Coronary artery CT: calcification score Vascular endothelial function (FMD) Intima-media complex thickness (IMT): upper arm IMT, carotid IMT ABI PWV Echocardiography: left atrium diameter (LAD), left ventricular end diastolic diameter (LADd), left ventricular ejection fraction (EF), extended early wave (e '), expanded early wave / extended early wave (E / e' ), Left ventricular mass coefficient (LVMI), ventricular septal thickness (IVS), left ventricular wall thickness (LVWT) Electrocardiogram: QTc Prescription drugs and injections (at the beginning and at the end / at the time of death): phosphorus adsorbents, vitamin D preparations, calcium receptor agonists, Mg-containing preparations Frequency of dialysis hypotension requiring replacement fluid Nutritional status: PCR, GNRI,% CGR, BMI, Alb, TP, ChE Periodic blood collection results: Hb, Ht, BUN, Cre, Na, Cl, Fe, ferritin, blood glucose (GA, HbA1c), B2-MG

Countries

Japan

Contacts

Public ContactYusaku Tanaka

Kawashima Hospital Clinical Engineering

tanakayusaku0724@gmail.com088-631-0110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026